1 / 19

Acute Myeloid Leukemias (AML)

Acute Myeloid Leukemias (AML). MLAB 1415: Hematology Keri Brophy-Martinez. Overview of AML. Also known as Acute myelocytic leukemia Acute myelogenous leukemia Acute nonlymphocytic leukemia

callum-rodriquez
Download Presentation

Acute Myeloid Leukemias (AML)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Acute Myeloid Leukemias (AML) MLAB 1415: Hematology Keri Brophy-Martinez

  2. Overview of AML • Also known as • Acute myelocytic leukemia • Acute myelogenous leukemia • Acute nonlymphocytic leukemia • Stem cell disorder characterized by malignant neoplastic proliferation and accumulation of immature and nonfunctional hematopoietic cells in the BM • Chemo/radiation • Exposure to benzene • History of MDS

  3. Overview of AML • All acute leukemias begin BEFORE clinical signs and symptoms occur • As the tumor volume expands, normal functional marrow cells decrease • Characterized by two major features • Ability to proliferate continuously • Due to mutations affecting growth factors • Transcription errors • Arrested development of normal cells • Lacks apoptosis

  4. Etiology • Classified by the cellular appearance of the primary stem cell • Common myeloid progenitor (CMP) • AML or ANLL • Common lymphoid progenitor (CLP) • ALL • Peak incidence in adults over 60

  5. Clinical findings • CLASSIC TRIAD • Anemia • Infection • Bleeding/easy bruising/petechiae • Fever • Shortness of breath • Fatigue • Weight loss • Pallor

  6. Lab Features: Peripheral blood • WBC count: • variable at diagnosis • ( 1-200 x 109/L) • >20% blasts present • Auer rods: fused primary granules in myeloblasts • RBCs • Decreased • Hgb < 10g/dL • Inclusions reflect rbc maturation defects • Howell-Jolly, Pappenheimer, basophilic stippling • nRBCs present • Platelets • Decreased • Hypogranular, giant forms • Megakaryocyte fragments

  7. Lab Features: MISC. • BONE MARROW • Hypercellular • Decreased fat content • >20 nonerythroid blasts • Fibrosis • MISC • Hyperuricemic • Increased LDH

  8. Who Classification of acute leukemia • AML with recurrent genetic abnormalities • AML with myelodysplasia- related changes • AML and MDS- therapy related • AML- not otherwise categorized

  9. WHO Classification of Acute MyelocyticLeukemias

  10. FAB Classification of Acute Leukemia

  11. M1: AML without maturation • Myeloblast with Auer rod • High N:C ratio • Fine chromatin • Prominent nuclei

  12. M2: Aml with maturation • All stages of neutrophil maturation • >20% myeloblasts • Auer rods common

  13. M3: promyelocytic leukemia (faggot cell) • Faggot cells with bundles of Auer rods • Genetic translocation t(15;17) • Hypergranulation

  14. M4: Acute myelomonocytic leukemia (AMML) • Monoblasts and promonocytes seen • Some neutrophil precursors seen • Vacuolization often seen

  15. M5: Acute monoblastic leukemia • Monoblasts • Promonocytes

  16. M6: Acute erythroid leukemia • Striking poik • High number of RBC precursors • >20 Myeloblasts

  17. M7: Acute Megakaryoblastic Leukemia • Peripheral blood • May see micromegakaryoblasts • Megakaryocyte fragments • Cytopenias • Dysplastic segmented neutrophils and platelets • Bone marrow • Often get “dry tap” • Fibrosis

  18. Prognosis of all AMLs and therapy • Death often occurs from infection and hemorrhage in weeks to months unless therapy is started • Chemotherapy • Reduces tumor load • Bone marrow transplants

  19. References • McKenzie, Shirlyn B., and J. Lynne. Williams. "Chapter 21." Introduction. Clinical Laboratory Hematology. Boston: Pearson, 2010. Print

More Related